SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-21-009148
Filing Date
2021-01-14
Accepted
2021-01-14 17:11:56
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B3 d82534d424b3.htm 424B3 4989582
2 GRAPHIC g82534g17q30.jpg GRAPHIC 109796
3 GRAPHIC g82534g18e70.jpg GRAPHIC 121414
4 GRAPHIC g82534g18r80.jpg GRAPHIC 94002
5 GRAPHIC g82534g18t90.jpg GRAPHIC 52091
6 GRAPHIC g82534g18t91.jpg GRAPHIC 46758
7 GRAPHIC g82534g18w60.jpg GRAPHIC 115059
8 GRAPHIC g82534g19u30.jpg GRAPHIC 70945
9 GRAPHIC g82534g19y20.jpg GRAPHIC 115072
10 GRAPHIC g82534g19y21.jpg GRAPHIC 79869
11 GRAPHIC g82534g38q81.jpg GRAPHIC 33875
12 GRAPHIC g82534g90w24.jpg GRAPHIC 19383
13 GRAPHIC g82534g92l55.jpg GRAPHIC 19523
14 GRAPHIC g82534g94c84.jpg GRAPHIC 22218
  Complete submission text file 0001193125-21-009148.txt   6173414
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-251567 | Film No.: 21529582
SIC: 2834 Pharmaceutical Preparations